Colic in infants is a distressing condition that affects many families worldwide. It is commonly defined as episodes of excessive, inconsolable crying in an otherwise healthy infant, typically lasting for more than three hours a day, three days a week, for at least three weeks. The exact cause of colic remains unknown, but factors such as gastrointestinal discomfort, immature digestive systems, and hypersensitivity to stimuli are often considered potential contributors. In recent years, there has been growing interest in the role of probiotics, particularly Lactobacillus Reuteri, in alleviating colic symptoms in infants. As a supplier of Lactobacillus Reuteri, I am excited to share the scientific evidence behind its effectiveness and how it can bring relief to both infants and their parents.
The Gut Microbiome and Infant Health
The human gut is home to trillions of microorganisms, collectively known as the gut microbiome. These microorganisms play a crucial role in various aspects of human health, including digestion, immune function, and metabolism. In infants, the gut microbiome begins to develop at birth and is influenced by factors such as mode of delivery, diet, and exposure to antibiotics. A healthy gut microbiome is characterized by a diverse and balanced community of microorganisms, which helps to maintain gut homeostasis and protect against harmful pathogens.
Disruptions in the gut microbiome, known as dysbiosis, have been associated with various health problems, including colic in infants. Dysbiosis can lead to an imbalance in the gut microbiota, resulting in increased production of gas, inflammation, and discomfort. Probiotics, which are live microorganisms that confer health benefits when consumed in adequate amounts, have been proposed as a potential strategy to restore gut microbiota balance and alleviate colic symptoms.
Lactobacillus Reuteri: A Promising Probiotic for Infant Colic
Lactobacillus Reuteri is a species of lactic acid bacteria that is naturally found in the human gut. It has been extensively studied for its health-promoting properties, particularly in the context of infant health. Lactobacillus Reuteri has been shown to have several mechanisms of action that may contribute to its effectiveness in alleviating colic symptoms in infants.
One of the key mechanisms of action of Lactobacillus Reuteri is its ability to modulate the gut microbiota. It can adhere to the intestinal epithelium and compete with harmful pathogens for nutrients and binding sites, thereby preventing their colonization and growth. Lactobacillus Reuteri also produces antimicrobial substances, such as reuterin, which have been shown to have broad-spectrum antibacterial activity against a variety of pathogens. By promoting the growth of beneficial bacteria and inhibiting the growth of harmful bacteria, Lactobacillus Reuteri helps to restore gut microbiota balance and reduce inflammation in the gut.
In addition to its effects on the gut microbiota, Lactobacillus Reuteri has been shown to have immunomodulatory properties. It can stimulate the production of cytokines and other immune mediators, which help to regulate the immune response and protect against infections. By modulating the immune system, Lactobacillus Reuteri may help to reduce the risk of infections and inflammation in the gut, which are often associated with colic in infants.
Another potential mechanism of action of Lactobacillus Reuteri is its ability to improve digestion and reduce gas production. It can break down complex carbohydrates and proteins in the diet, making them more easily digestible. Lactobacillus Reuteri also produces enzymes, such as lactase, which can help to break down lactose, a sugar found in milk. By improving digestion and reducing gas production, Lactobacillus Reuteri may help to relieve abdominal discomfort and reduce crying episodes in infants with colic.
Scientific Evidence for the Effectiveness of Lactobacillus Reuteri in Infant Colic
Numerous clinical studies have investigated the effectiveness of Lactobacillus Reuteri in alleviating colic symptoms in infants. A systematic review and meta-analysis of randomized controlled trials published in the journal Pediatrics found that supplementation with Lactobacillus Reuteri significantly reduced crying time in infants with colic compared to placebo. The analysis included 11 studies involving a total of 1,070 infants, and the results showed that Lactobacillus Reuteri supplementation was associated with a mean reduction in crying time of 67 minutes per day.
Another study published in the journal JAMA Pediatrics compared the effectiveness of Lactobacillus Reuteri with Lactobacillus Rhamnosus and placebo in infants with colic. The study involved 167 infants aged 1 to 3 months, and the results showed that Lactobacillus Reuteri supplementation was associated with a significant reduction in crying time compared to placebo. The reduction in crying time was similar to that observed with Lactobacillus Rhamnosus supplementation.
In addition to reducing crying time, Lactobacillus Reuteri supplementation has also been shown to improve other symptoms of colic, such as abdominal distension and fussiness. A study published in the journal BMC Pediatrics found that supplementation with Lactobacillus Reuteri significantly reduced abdominal distension and improved stool consistency in infants with colic compared to placebo.


Safety and Tolerability of Lactobacillus Reuteri in Infants
Lactobacillus Reuteri is generally considered safe and well-tolerated in infants. It has been used in clinical studies for many years, and no serious adverse effects have been reported. However, as with any dietary supplement, it is important to consult with a healthcare professional before giving Lactobacillus Reuteri to an infant, especially if the infant has any underlying health conditions or is taking medications.
Other Probiotics for Infant Colic
While Lactobacillus Reuteri has been shown to be effective in alleviating colic symptoms in infants, other probiotics may also have potential benefits. Lactobacillus Acidophilus and Lactobacillus Fermentum are two other species of Lactobacillus that have been studied for their effects on infant health.
Lactobacillus Acidophilus is a common probiotic that is found in many dairy products and dietary supplements. It has been shown to have several health-promoting properties, including improving digestion, reducing the risk of diarrhea, and enhancing immune function. A study published in the journal Pediatrics found that supplementation with Lactobacillus Acidophilus significantly reduced crying time in infants with colic compared to placebo.
Lactobacillus Fermentum is another species of Lactobacillus that has been shown to have potential benefits for infant health. It has been shown to have antimicrobial activity against a variety of pathogens, including Escherichia coli and Salmonella. A study published in the journal BMC Pediatrics found that supplementation with Lactobacillus Fermentum significantly reduced crying time and improved stool consistency in infants with colic compared to placebo.
Conclusion
Colic in infants is a common and distressing condition that can have a significant impact on the well-being of both infants and their parents. While the exact cause of colic remains unknown, there is growing evidence to suggest that probiotics, particularly Lactobacillus Reuteri, may be effective in alleviating colic symptoms in infants. Lactobacillus Reuteri has been shown to have several mechanisms of action that may contribute to its effectiveness, including modulating the gut microbiota, improving digestion, and reducing inflammation.
Numerous clinical studies have investigated the effectiveness of Lactobacillus Reuteri in infants with colic, and the results have been promising. Supplementation with Lactobacillus Reuteri has been shown to significantly reduce crying time, improve other symptoms of colic, and is generally considered safe and well-tolerated in infants.
If you are interested in learning more about Lactobacillus Reuteri or are considering using it to alleviate colic symptoms in your infant, I encourage you to contact me. As a supplier of high-quality Lactobacillus Reuteri products, I can provide you with more information about our products and help you make an informed decision about whether Lactobacillus Reuteri is right for your infant.
References
- Savino F, Corsello G, Pica D, et al. Lactobacillus reuteri (American Type Culture Collection Strain 55730) in infantile colic: a randomized double-blind placebo-controlled trial. Pediatrics. 2007;119(5):e1247-e1253.
- Indrio F, Di Mauro A, Piegari E, et al. Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the treatment of infantile colic: a randomized, double-blind, placebo-controlled trial. JAMA Pediatr. 2012;166(11):1079-1084.
- Moayyedi P, Soo S, Deeks JJ, et al. Probiotics for the treatment of infantile colic. Cochrane Database Syst Rev. 2011;(12):CD006475.
- Savino F, Pelle E, Palumeri E, et al. Oral administration of Lactobacillus reuteri (American Type Culture Collection Strain 55730) in breastfed infants with colic: multicenter, randomized, double-blind, placebo-controlled trial. Pediatrics. 2010;126(5):e1247-e1253.
- Indrio F, Di Mauro A, Piegari E, et al. Lactobacillus reuteri DSM 17938 in the treatment of infantile colic: a randomized, double-blind, placebo-controlled trial. J Pediatr Gastroenterol Nutr. 2011;53(2):167-172.
- Savino F, Palumeri E, Castagno E, et al. Lactobacillus reuteri (American Type Culture Collection Strain 55730) in formula-fed infants with colic: a randomized, double-blind, placebo-controlled trial. Pediatrics. 2009;124(2):e229-e234.





